Diabetes
55:2640-2644,
2006
DOI: 10.2337/db06-0355
© 2006 by the American Diabetes Association
Association Analysis of 6,736 U.K. Subjects Provides Replication and Confirms TCF7L2 as a Type 2 Diabetes Susceptibility Gene With a Substantial Effect on Individual Risk
Christopher J. Groves1,
Eleftheria Zeggini1,2,
Jayne Minton3,
Timothy M. Frayling3,
Michael N. Weedon3,
Nigel W. Rayner1,2,
Graham A. Hitman4,
Mark Walker5,
Steven Wiltshire2,
Andrew T. Hattersley3, and
Mark I. McCarthy1,2
1 Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, U.K
2 Wellcome Trust Centre for Human Genetics, Headington, Oxford, U.K
3 Department of Diabetes Research and Vascular Medicine, Peninsula Medical School, Exeter, U.K
4 Department of Diabetes and Metabolic Medicine, Barts and the London, Queen Mary School of Medicine and Dentistry, University of London, London, U.K
5 Department of Medicine, School of Medicine, Newcastle University, Newcastle upon Tyne, U.K
Address correspondence and reprint requests to Prof. Mark McCarthy, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, U.K. E-mail: mark.mccarthy{at}drl.ox.ac.uk
Abbreviations:
SNP, single nucleotide polymorphism
Recent data suggest that common variation in the transcription factor 7-like 2 (TCF7L2) gene is associated with type 2 diabetes. Evaluation of such associations in independent samples provides necessary replication and a robust assessment of effect size. Using four TCF7L2 single nucleotide polymorphisms (SNPs; including the two most associated in the previous study), we conducted a case-control study in 2,158 type 2 diabetic subjects and 2,574 control subjects and a family-based association analysis in 388 parent-offspring trios all from the U.K. All SNPs showed powerful associations with diabetes in the case-control analysis, with strongest effects at rs7903146 (allele-wise relative risk 1.36 [95% CI 1.24–1.48], P = 1.3 x 10–11). Data were consistent with a multiplicative model. The family-based analyses provided independent evidence for association at all loci (e.g., rs4506565, 62% transmission, P = 7 x 10–5) with no parent-of-origin effects. The frequency of diabetes-associated TCF7L2 genotypes was greater in cases ascertained for positive family history and early onset (rs4606565, P = 0.02); the population-attributable risk, estimated from the least-selected cases, is 16%. The overall evidence for association for these variants (P = 4.4 x 10–14 combining case-control and family-based analyses for rs4506565) exceeds genome-wide significance criteria and clearly establishes TCF7L2 as a type 2 diabetes susceptibility gene of substantial importance.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Shu, N. S. Sauter, F. T. Schulthess, A. V. Matveyenko, J. Oberholzer, and K. Maedler
Transcription Factor 7-Like 2 Regulates {beta}-Cell Survival and Function in Human Pancreatic Islets
Diabetes,
March 1, 2008;
57(3):
645 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Omori, Y. Tanaka, A. Takahashi, H. Hirose, A. Kashiwagi, K. Kaku, R. Kawamori, Y. Nakamura, and S. Maeda
Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 With Susceptibility to Type 2 Diabetes in a Japanese Population
Diabetes,
March 1, 2008;
57(3):
791 - 795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Guo, R. L. Hanson, M. Traurig, Y. Li Muller, L. Ma, J. Mack, S. Kobes, W. C. Knowler, C. Bogardus, and L. J. Baier
TCF7L2 Is Not a Major Susceptibility Gene for Type 2 Diabetes in Pima Indians: Analysis of 3,501 Individuals
Diabetes,
December 1, 2007;
56(12):
3082 - 3088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-C. Chang, T.-J. Chang, Y.-D. Jiang, S.-S. Kuo, K.-C. Lee, K. C. Chiu, and L.-M. Chuang
Association Study of the Genetic Polymorphisms of the Transcription Factor 7-Like 2 (TCF7L2) Gene and Type 2 Diabetes in the Chinese Population
Diabetes,
October 1, 2007;
56(10):
2631 - 2637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Sale, S. G. Smith, J. C. Mychaleckyj, K. L. Keene, C. D. Langefeld, T. S. Leak, P. J. Hicks, D. W. Bowden, S. S. Rich, and B. I. Freedman
Variants of the Transcription Factor 7-Like 2 (TCF7L2) Gene Are Associated With Type 2 Diabetes in an African-American Population Enriched for Nephropathy
Diabetes,
October 1, 2007;
56(10):
2638 - 2642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Y. Ng, C. H. T. Tam, V. K. L. Lam, W.-Y. So, R. C. W. Ma, and J. C. N. Chan
Replication and Identification of Novel Variants at TCF7L2 Associated with Type 2 Diabetes in Hong Kong Chinese
J. Clin. Endocrinol. Metab.,
September 1, 2007;
92(9):
3733 - 3737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Pearson, L. A. Donnelly, C. Kimber, A. Whitley, A. S.F. Doney, M. I. McCarthy, A. T. Hattersley, A. D. Morris, and C. N.A. Palmer
Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas: A GoDARTs Study
Diabetes,
August 1, 2007;
56(8):
2178 - 2182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J.F. Loos, P. W. Franks, R. W. Francis, I. Barroso, F. M. Gribble, D. B. Savage, K. K. Ong, S. O'Rahilly, and N. J. Wareham
TCF7L2 Polymorphisms Modulate Proinsulin Levels and {beta}-Cell Function in a British Europid Population
Diabetes,
July 1, 2007;
56(7):
1943 - 1947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Meirhaeghe, M. S. Sandhu, M. I. McCarthy, P. de Groote, D. Cottel, D. Arveiler, J. Ferrieres, C. J. Groves, A. T. Hattersley, G. A. Hitman, et al.
Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations
Hum. Mol. Genet.,
June 1, 2007;
16(11):
1343 - 1350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. L. Duan, M.-P. Dube, N. Frasure-Smith, A. Barhdadi, F. Lesperance, P. Theroux, J. St-Onge, G. A. Rouleau, and J. M. McCaffery
Additive Effects of Obesity and TCF7L2 Variants on Risk for Type 2 Diabetes Among Cardiac Patients
Diabetes Care,
June 1, 2007;
30(6):
1621 - 1623.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Korner, J. Berndt, M. Stumvoll, W. Kiess, and P. Kovacs
TCF7L2 Gene Polymorphisms Confer an Increased Risk for Early Impairment of Glucose Metabolism and Increased Height in Obese Children
J. Clin. Endocrinol. Metab.,
May 1, 2007;
92(5):
1956 - 1960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Watanabe, H. Allayee, A. H. Xiang, E. Trigo, J. Hartiala, J. M. Lawrence, and T. A. Buchanan
Transcription Factor 7-Like 2 (TCF7L2) Is Associated With Gestational Diabetes Mellitus and Interacts With Adiposity to Alter Insulin Secretion in Mexican Americans
Diabetes,
May 1, 2007;
56(5):
1481 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Clee and A. D. Attie
The Genetic Landscape of Type 2 Diabetes in Mice
Endocr. Rev.,
February 1, 2007;
28(1):
48 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Florez, R. Saxena, W. Winckler, N. P. Burtt, P. Almgren, K. Bengtsson Bostrom, T. Tuomi, D. Gaudet, K. G. Ardlie, M. J. Daly, et al.
The Kruppel-Like Factor 11 (KLF11) Q62R Polymorphism Is Not Associated With Type 2 Diabetes in 8,676 People
Diabetes,
December 1, 2006;
55(12):
3620 - 3624.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|